We have separately coupled a modified thyrotropin-releasing hormone (TRH) molecule to two diphtheria toxin-related polypeptides, CRM26 and CRM45. Both polypeptides are enzymatically active but only CRM45 contains the hydrophobic domain of the toxin molecule. The TRH-CRM45 conjugate caused a 50% inhibition of protein synthesis in GH3 rat pituitary cells at 3 X 10(-9) M. CRM45 alone was 200 to 500 times less toxic than the conjugate. Intoxication by TRH-CRM45 was prevented by excess TRH, preincubation with diphtheria antitoxin, or reduction of the disulfide cross-link. In addition, TRH-CRM45 was no more toxic than CRM45 itself to 3T3 cells which lack TRH receptors. In contrast, TRH-CRM26, although it retained enzymatic activity, was nontoxic for GH3 cells even at 10(-7) M. Binding experiments showed that both conjugates compete for TRH receptors with comparable affinities. The potential role of the hydrophobic domain in toxin entry is discussed.
No takes yet. Share an insight, caveat, or question.
Bacha et al. (1983) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: